Preventing HIV Infection Among Injecting Drug Users in High-Risk Countries: An Assessment of the Evidence (2007)
Chapter: Appendix A Agenda for Information-Gathering Meeting, Geneva, December 2005
Appendix A
Agenda for Information-Gathering Meeting, Geneva, December 2005
COMMITTEE ON THE PREVENTION OF HIV INFECTION AMONG INJECTING DRUG USERS IN HIGH-RISK COUNTRIES
December 19–20, 2005
Geneva, Switzerland
December 19, 2005
|
9:00–9:15 a.m. |
Welcome, Introductions, and Opening Statement |
|
|
Hugh Tilson, M.D., Dr.PH. Committee Chair |
|
9:15–9:45 a.m. |
Charge to the Committee |
|
|
Peter Piot, M.D., Ph.D. Executive Director, UNAIDS Under Secretary-General of the United Nations |
|
9:45–10:15 a.m. |
Overview of Addiction |
|
|
Michael Farrell, MRCPsych Reader in Addiction Psychiatry, National Addiction Centre, Institute of Psychiatry, King’s College, London |
|
10:15–11:00 a.m. |
Epidemiology of HIV/AIDS Among IDUs in High-Risk Countries and the Global Response |
|
|
Peter Ghys, M.D. Acting Associate Director, Epidemic Monitoring and Prevention, Department of Policy, Evidence and Partnerships, UNAIDS |
|
|
Catherine Anita Hankins, M.D., MSc, FRCPC Associate Director of Policy, Evidence and Partnerships Chief Scientific Adviser UNAIDS |
|
11:00–11:15 a.m. |
Break |
|
11:15–12:45 p.m. |
Evidence Regarding HIV Prevention for IDUs |
|
|
Overview: Gerry V. Stimson Ph.D. Emeritus Professor, Imperial College London, and Executive Director, International Harm Reduction Association |
|
|
Review of needle and syringe exchange programs: Dr. Alex Wodak FRACP, FChAM Director, Alcohol and Drug Service St. Vincent’s Hospital, Darlinghurst, Australia |
|
|
Review of needle and syringe exchange programs: Kerstin Käll, M.D., Ph.D. Clinic for Dependency Disorders University Hospital, Linköping, Sweden |
|
|
Review of drug treatment strategies: Michael Farrell, MRCPsych Reader in Addiction Psychiatry, National Addiction Centre, Institute of Psychiatry, King’s College, London |
|
12:45–1:45 p.m. |
Lunch |
|
1:45–3:15 p.m. |
Country Perspectives Panel: Asian and Pacific Countries |
|
|
Zhang Fujie, M.D. Director, Division of Treatment and Care National Center for AIDS-STD Control and Prevention, Chinese Center for Disease of Control and Prevention |
|
|
Adeeba Kamarulzaman, MBBS, FRACP Head, Infectious Diseases Unit Department of Medicine University of Malaya Medical Centre, Malaysia |
|
|
Chris Beyrer, M.D., M.P.H. Associate Professor, Department of Epidemiology Director, Johns Hopkins Fogarty AIDS International Training and Research Program Director, Johns Hopkins Center for Public Health & Human Rights Johns Hopkins Bloomberg School of Public Health (discussing Thailand) |
|
3:15–3:30 p.m. |
Break |
|
3:30–5:45 p.m. |
Country Perspectives Panel: Former Soviet States, Central, and Eastern European Countries |
|
|
Saulius Caplinskas, M.D., Ph.D. Director, Lithuanian AIDS Centre Assoc. Prof., Mykolas Romeris University |
|
|
Monica Ciupagea M.D. Program Officer International Harm Reduction Development Program Open Society Institute, Budapest |
|
|
Oleg Tchestnov, M.D. Deputy Director of the International Department Ministry of Health, Russia |
|
|
Ksenia Eroshina, M.P.H., Ph.D. Head of Monitoring & Evaluation Department Open Health Institute, Moscow, Russia |
|
|
Alexey Mazus M.D. Head of Moscow AIDS Center |
|
|
Inga Upmace, M.D. Deputy Director, AIDS Prevention Center, Latvia Steering Committee member of CEE-HRN (Central and Eastern Europe Harm Reduction Network) |
|
|
Lily Hyde Harm Reduction and IEC Consultant International HIV/AIDS Alliance in Ukraine |
|
6:30 p.m. |
Reception for all meeting participants at the ILO building, hosted by UNAIDS |
December 20, 2005
|
8:30–10:00 a.m. |
Lessons Learned: Experiences in the United States, Canada, Australia, and Western European Countries |
|
|
Don C. Des Jarlais, Ph.D. Director of Research, Baron Edmond de Rothschild Chemical Institute, Beth Israel Medical Center Professor of Epidemiology, Department of Epidemiology and Population Health, Albert Einstein College of Medicine, New York |
|
|
Alex Wodak, FRACP, FChAM Director, Alcohol and Drug Service St. Vincent’s Hospital, Darlinghurst, Australia |
|
|
Roel A. Coutinho, M.D., Ph.D. Director, Centre for Infectious Disease Control National Institute for Health and the Environment, The Netherlands |
|
|
Gerry V. Stimson Ph.D. Emeritus Professor, Imperial College London, and Executive Director, International Harm Reduction Association |
|
10:00–10:15 a.m. |
Break |
|
10:15–12:30 p.m. |
Illicit Drug Policies and the HIV Epidemic |
|
|
Andrew Ball, M.B., B.S., FChAM Senior Strategy and Operations Advisor Department of HIV/AIDS World Health Organization |
|
|
Christian Kroll Senior Coordinator, HIV/AIDS Unit Global Coordinator on HIV/AIDS UNODC |
|
|
Chris Beyrer, M.D., M.P.H. Associate Professor, Department of Epidemiology Director, Johns Hopkins Fogarty AIDS International Training and Research Program Director, Johns Hopkins Center for Public Health & Human Rights Johns Hopkins Bloomberg School of Public Health |
|
|
Tomas Hallberg Director, European Cities against Drugs (ECAD) Stockholm, Sweden |
|
|
George Zazulin St. Petersburg Regional Director, ECAD, Russia |
|
|
Alex Wodak, FRACP, FChAM Director, Alcohol and Drug Service St. Vincent’s Hospital, Darlinghurst, Australia |
|
|
Raminta Stuikyte Director, Central and Eastern European Harm Reduction Network |
|
12:30–1:30 p.m. |
Lunch |
|
1:30–2:30 p.m. |
Community Perspectives |
|
|
Mr. Loon Gangte (not able to attend; sent written remarks) President, Delhi Network of Positive People, India Regional Coordinator for South Asia Collaborative Fund for HIV Treatment Preparedness |
|
|
Mr. Samuel Nugraha Partnership and Network Assistant UNAIDS Secretariat Indonesia |
|
2:30–3:00 p.m. |
Methodological Considerations in Evaluating Evidence |
|
|
Don C. Des Jarlais, Ph.D. Director of Research, Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center Professor of Epidemiology, Department of Epidemiology and Population Health, Albert Einstein College of Medicine, New York |
|
3:00–3:30 p.m. |
Public Comments |
|
3:30 p.m. |
Adjourn |
